>“And specifically, that was Thomas Madden, that was Pieter Cullis and Ian MacLachlan, who at the University of British Columbia developed a lipid nanoparticle that was required to first, demonstrate the ability to actually do what was called ‘gene silencing’ in monkeys and then, took that technology, after a lawsuit, which was a $65 million lawsuit – the settlement of that lawsuit in 2012 – and for those in Canada, look up that lawsuit – it was the lawsuit between Protiva, Tekmira, AlCana Therapeutics and the University of British Columbia. >After the $65 million settlement was paid in that particular case in 2015, AlCana Therapeutics, owned by Thomas Madden and Pieter Cullis sub-licensed the lipid nanoparticle technology to Moderna for the development of an mRNA vaccine during the gain-of-function moratorium, in violation of US and Canadian law. they make money from the delivery method. they will be trying to find ways to use that 'technology' all over the place.